Tech Transfer Roundup: Mustang, Juno Advance Efforts With Immuno-Oncology
Executive Summary
While Mustang was acquiring CAR-T intellectual property from Harvard and Juno licensed gamma-secretase inhibitor IP from OncoTracker and Fred Hutchinson for use with its CAR-Ts, Ocugen and Tamid licensed gene therapy research for ophthalmic uses.